These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9411236)

  • 1. Treatment of prostate cancer with goserelin and radiotherapy.
    Vicini FA; Kini VR; Martinez AA
    N Engl J Med; 1997 Dec; 337(23):1693-4. PubMed ID: 9411236
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of prostate cancer with goserelin and radiotherapy.
    Schoen SS
    N Engl J Med; 1997 Dec; 337(23):1693; author reply 1694. PubMed ID: 9411235
    [No Abstract]   [Full Text] [Related]  

  • 3. RTOG study shows improved survival for prostate cancer patients given adjuvant goserelin.
    Oncology (Williston Park); 2005 Aug; 19(9):1142. PubMed ID: 16402596
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer--the therapeutic challenge of locally advanced disease.
    Blasko JC; Lange PH
    N Engl J Med; 1997 Jul; 337(5):340-1. PubMed ID: 9233872
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating prostate cancer: another step forward.
    Harv Mens Health Watch; 1998 May; 2(10):7. PubMed ID: 9577263
    [No Abstract]   [Full Text] [Related]  

  • 7. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer: risk categories and role of hormones and radiotherapy.
    Lukka H
    Can J Urol; 2002 Jun; 9 Suppl 1():26-9. PubMed ID: 12121592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goserelin and locally advanced prostate cancer: new indication. Pros and cons.
    Prescrire Int; 2000 Jun; 9(47):75-6. PubMed ID: 11010743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla].
    Bolla M
    Recenti Prog Med; 2001 Feb; 92(2):128-9. PubMed ID: 11294104
    [No Abstract]   [Full Text] [Related]  

  • 11. [Integrated (surgical and hormonal) treatment of advanced prostatic carcinoma. Comment on the study and the interview with Edward M. Messing].
    Prayer Galetti T
    Recenti Prog Med; 2001 Feb; 92(2):126-7. PubMed ID: 11294103
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
    Pilepich MV; Winter K; Lawton CA; Krisch RE; Wolkov HB; Movsas B; Hug EB; Asbell SO; Grignon D
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1285-90. PubMed ID: 15817329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer.
    Fleshner N; Keane TE; Lawton CA; Mulders PF; Payne H; Taneja SS; Morris T
    Prostate Cancer Prostatic Dis; 2008; 11(1):46-52. PubMed ID: 17607304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal administration in prostate cancer: a caring approach.
    Ebersole ME
    Urol Nurs; 1996 Mar; 16(1):23-6. PubMed ID: 8826392
    [No Abstract]   [Full Text] [Related]  

  • 15. ASTRO plenary session touts top new research. American Society for Therapeutic Radiology and Oncology.
    Volkers N
    J Natl Cancer Inst; 1999 Dec; 91(24):2075-7. PubMed ID: 10601375
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?
    Horwitz EM; Hanlon AL; Pinover WH; Hanks GE
    Radiat Oncol Investig; 1999; 7(4):249-59. PubMed ID: 10492166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in radiotherapy and improved outcomes in prostate cancer.
    Milito SJ; Thomas CR; Turrisi AT
    J S C Med Assoc; 1998 Jun; 94(6):257-62. PubMed ID: 9648407
    [No Abstract]   [Full Text] [Related]  

  • 18. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
    Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
    Di Silverio F; Serio M; Costantini A
    J Chemother; 1989 Jul; 1(4 Suppl):1231-4. PubMed ID: 16312846
    [No Abstract]   [Full Text] [Related]  

  • 20. [Zoladex (ICI) in the therapy of prostatic cancer patients].
    Popko AS; Dokshin KL
    Urol Nefrol (Mosk); 1996; (6):53-5. PubMed ID: 9036615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.